相关实验视频

Updated: Jul 16, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

肺腺癌中的miRNAs:作用,诊断,预后和治疗

Yongan Song¹, Leonardo Kelava², István Kiss¹

¹Department of Public Health Medicine, University of Pécs Medical School, Szigeti Str. 12, 7624 Pécs, Hungary.

International journal of molecular sciences

|September 9, 2023

概括

本综述侧重于肺腺癌 (LUAD),一种常见的癌症中的微RNAs (miRNAs). 我们探索了它们的诊断,预后和治疗潜力,填补了当前研究中的空白.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
遗传学是一个遗传学.

背景情况:

肺腺癌 (LUAD) 是最常见的肺癌类型,也是全球癌症死亡的主要原因.
微RNAs (miRNAs) 是基因表达的关键调节者,与各种癌症有关.
现有的关于miRNAs和肺癌的评论缺乏对LUAD的具体关注.

研究的目的:

为了提供一个全面的概述研究的miRNAs在LUAD.
突出miRNAs的诊断,预后和治疗潜力,特别是在LUAD中.
为了解决关于 miRNAs 在 LUAD 中文献中的现有空白.

主要方法:

对调查肺腺癌中miRNAs的研究的文献综述.
综合了关于miRNAs在LUAD病变发生,诊断,预后和治疗中的作用的发现.
确定关键的miRNA及其与LUAD相关的目标基因.

主要成果:

微RNA显示出作为LUAD诊断和预后的生物标志物的巨大潜力.
特定的miRNA与LUAD的发展,进展和对治疗的反应有关.
miRNAs为针对LUAD的新型治疗策略提供了有希望的途径.

结论:

微RNA是LUAD中的关键参与者,并且对临床应用有很大的前景.
对基于miRNA的诊断和治疗方法的进一步研究可能会对LUAD患者的结果产生重大影响.
本综述巩固了当前的知识,并确定了LUAD中miRNAs的未来研究方向.

关键词:

卢阿德 (Luad) 的意思是说.诊断诊断诊断诊断诊断诊断这是一个小RNARNA.瘤原性瘤性瘤性瘤性瘤性预后预后预后治疗疗法治疗疗法治疗疗法这是一种瘤抑制剂.

更多相关视频

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

相关概念视频

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...